1. Home
  2. NBTX vs AVD Comparison

NBTX vs AVD Comparison

Compare NBTX & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • AVD
  • Stock Information
  • Founded
  • NBTX 2003
  • AVD 1969
  • Country
  • NBTX France
  • AVD United States
  • Employees
  • NBTX N/A
  • AVD N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • AVD Agricultural Chemicals
  • Sector
  • NBTX Health Care
  • AVD Industrials
  • Exchange
  • NBTX Nasdaq
  • AVD Nasdaq
  • Market Cap
  • NBTX 201.9M
  • AVD 165.8M
  • IPO Year
  • NBTX 2020
  • AVD N/A
  • Fundamental
  • Price
  • NBTX $3.75
  • AVD $5.28
  • Analyst Decision
  • NBTX Strong Buy
  • AVD Strong Buy
  • Analyst Count
  • NBTX 1
  • AVD 3
  • Target Price
  • NBTX $12.00
  • AVD $16.67
  • AVG Volume (30 Days)
  • NBTX 8.9K
  • AVD 209.6K
  • Earning Date
  • NBTX 09-18-2024
  • AVD 03-13-2025
  • Dividend Yield
  • NBTX N/A
  • AVD 1.14%
  • EPS Growth
  • NBTX N/A
  • AVD N/A
  • EPS
  • NBTX N/A
  • AVD N/A
  • Revenue
  • NBTX $45,220,186.00
  • AVD $553,839,000.00
  • Revenue This Year
  • NBTX N/A
  • AVD N/A
  • Revenue Next Year
  • NBTX N/A
  • AVD $5.98
  • P/E Ratio
  • NBTX N/A
  • AVD N/A
  • Revenue Growth
  • NBTX 526.17
  • AVD N/A
  • 52 Week Low
  • NBTX $2.76
  • AVD $4.26
  • 52 Week High
  • NBTX $7.51
  • AVD $14.28
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 53.25
  • AVD 43.59
  • Support Level
  • NBTX $3.60
  • AVD $5.36
  • Resistance Level
  • NBTX $3.95
  • AVD $5.77
  • Average True Range (ATR)
  • NBTX 0.19
  • AVD 0.25
  • MACD
  • NBTX -0.01
  • AVD -0.08
  • Stochastic Oscillator
  • NBTX 38.18
  • AVD 2.78

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: